OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical indicators of treatment-resistant psychosis
Sophie E. Legge, Charlotte Dennison, Antonio F. Pardiñas, et al.
The British Journal of Psychiatry (2019) Vol. 216, Iss. 5, pp. 259-266
Open Access | Times Cited: 78

Showing 51-75 of 78 citing articles:

Update on the genetic architecture of schizophrenia
Franziska Degenhardt
Medizinische Genetik (2020) Vol. 32, Iss. 1, pp. 19-24
Open Access | Times Cited: 6

Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort study
Edward Millgate, Sophie Smart, Antonio F. Pardiñas, et al.
Schizophrenia Research (2023) Vol. 255, pp. 173-181
Open Access | Times Cited: 2

The association between clinical, sociodemographic, familial, and environmental factors and treatment resistance in schizophrenia: A machine-learning-based approach
Carmen F.M. van Hooijdonk, Marieke van der Pluijm, Bart M. de Vries, et al.
Schizophrenia Research (2023) Vol. 262, pp. 132-141
Open Access | Times Cited: 2

Latent Profiles of Premorbid Adjustment in Schizophrenia and Their Correlation with Measures of Recovery
Alejandra Caqueo‐Urízar, Felipe Ponce, Carla Semir-González, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3840-3840
Open Access | Times Cited: 4

Impact of cannabis use on outcomes of patients admitted to an involuntary psychiatric unit: A retrospective cohort study
Stéphan Soler, Christine Montout, Berengere Pepin, et al.
Journal of Psychiatric Research (2021) Vol. 138, pp. 507-513
Open Access | Times Cited: 5

The impact of manic symptoms in first‐episode psychosis: Findings from the UK National EDEN study
Steven Marwaha, Danielle Hett, Sonia Johnson, et al.
Acta Psychiatrica Scandinavica (2021) Vol. 144, Iss. 4, pp. 358-367
Open Access | Times Cited: 4

Causes and Outcome of Psychosis
Cecilia Casetta, Adrianna P. Kępińska, Simona A. Stilo, et al.
Cambridge University Press eBooks (2024), pp. 224-240
Closed Access

Genome-wide association analysis of treatment resistant schizophrenia for variant discovery and polygenic assessment
Hasan Çağın Lenk, Elise Koch, Kevin S. O’Connell, et al.
Research Square (Research Square) (2024)
Closed Access

Fetal Gene Regulatory Gene Deletions are Associated with Poor Cognition and Altered Cortical Morphology in Schizophrenia and Community-Based Samples
Jennifer K. Forsyth, Jinhan Zhu, Ariana S. Chavannes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Assessing the validity of a self-reported clinical diagnosis of schizophrenia
Grace Woolway, Sophie E. Legge, Amy Lynham, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access

Early Treatment-Resistance in First Episode Psychosis
Piyumi Fernando, Johanna Strauß, Elias Wagner, et al.
Pharmacopsychiatry (2024)
Closed Access

Acute Behavioral and Neurochemical Effects of Sulpiride in Adult Zebrafish
David S. Galstyan, A. S. Lebedev, Nikita P. Ilyin, et al.
Neurochemical Research (2024) Vol. 50, Iss. 1
Closed Access

Genetic Architecture of Schizophrenia: Transitioning from Candidate Genes to Polygenic Risk Scores
Mahbod Ebrahimi, Niki Akbarian, Kowsar Teymouri, et al.
Royal Society of Chemistry eBooks (2024), pp. 1-18
Open Access

Towards personalized pharmacology: Antipsychotics and schizophrenia
Louise Carton, Régis Bordet, François Montastruc, et al.
Therapies (2020) Vol. 76, Iss. 2, pp. 137-147
Open Access | Times Cited: 3

Genetic variation in glutamatergic genes moderates the effects of childhood adversity on brain volume and IQ in treatment-resistant schizophrenia
Suriati Mohamed Saini, Chad A. Bousman, Serafino G. Mancuso, et al.
Schizophrenia (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 1

Prevalence and predictors of treatment-resistant schizophrenia in a tertiary hospital in Northeast Brazil
Douglas de Sousa Soares, Danyelle Rolim Carvalho, Mellanie Dellylah Trinta Ribeiro, et al.
Trends in Psychiatry and Psychotherapy (2021)
Open Access | Times Cited: 3

Genomic treatment response prediction in schizophrenia
Sophie E. Legge, Antonio F. Pardiñas, James Walters
Elsevier eBooks (2019), pp. 413-422
Closed Access | Times Cited: 2

Cannabis et troubles psychotiques
Alain Dervaux
La Presse Médicale Formation (2020) Vol. 1, Iss. 4, pp. 394-404
Open Access | Times Cited: 2

Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorder
Cynthia Okhuijsen‐Pfeifer, Marte Z. van der Horst, Chad A. Bousman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2

Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study
Edward Millgate, Eugenia Kravariti, Alice Egerton, et al.
BMJ Open (2021) Vol. 11, Iss. 11, pp. e054160-e054160
Open Access | Times Cited: 2

Increased Prevalence of Rare Copy Number Variants in Treatment-Resistant Psychosis
Martilias S. Farrell, Tyler Dietterich, Matthew K. Harner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1

On the bumpy road of psychotic disorders
Carmen Francina Maria van Hooijdonk
(2023)
Open Access

Scroll to top